SQZ Biotechnologies Co
SQZDelisted Jul 19, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001604477
SQZ Biotechnologies Co was delisted on Jul 19, 2023; its insiders filed their last Form 4 on Jun 15, 2023; 31 institutions reported holding it in 13F filings for Q2 2023, worth $2.96M in total; Maverick Capital was the only superinvestor holding it.
Q2 2023 vs. Q1 2023
How the institutions holding SQZ Biotechnologies Co changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 32 | 1 | 31 | 0 |
| Shares | 11.4M | 5.00K | 11.0M | −387.0K (−3.4%) |
| Value | $6.36M | $3.00K | $2.96M | −$3.40M (−53.4%) |
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held SQZ Biotechnologies Co at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Prudential Financial Inc | 40,200 | $10.9K | 0.00% |
| Susquehanna International Group, LLP | 29,231 | $7.89K | 0.00% |
| Royal Bank of Canada | 646 | $0 | 0.00% |
Sold out (3)
Institutions that held SQZ Biotechnologies Co at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Two Sigma Securities, LLC | 36,069 | $20.2K |
| Virtu Financial LLC | 17,075 | $10.0K |
| National Bank of Canada | 1,000 | $558 |
Not filed for Q2 2023 yet (1)
Institutions that held SQZ Biotechnologies Co at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Baldrige Asset Management LLC | 5,000 | $3.00K |